We extended our analysis into the c-MYC and PD-L1 expression downregulation by comparing the expression of the c-MYC and PD-L1 in the lungs of the vector + nanocage-treated tumor-bearing mice and the dose-dependent treatment groups (Figures 5A–C). The gene discussed is MYC; the disease is neoplasm.